IP Library Assignment 048400/0438
Patent Assignment
Reel/Frame 048400/0438

Assignment of Assignor's Interest

Recorded: 2019-02-21 Pages: 12
Assignor
UNIVERSITY OF LEEDS
Executed: 2010-06-10
Assignee
THE MEDICINES COMPANY
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
Covered Properties (2)
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Patent: 8,629,100 →
Application: 13/950,202 →
Publication: US 2013/0310308
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Patent: 9,220,749 →
Application: 14/101,645 →
Publication: US 2014/0100157
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest Feb 21, 2019
From: WILCOX, MARK HARVEY; BAINES, SIMON
To: UNIVERSITY OF LEEDS
Reel/Frame 048400/0254 →
Assignment of Assignor's Interest Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS REEVES, JR
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0331 →
Assignment of Assignor's Interest Feb 21, 2019
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 048400/0485 →
Assignment of Assignor's Interest Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Amended and Restated Intellectual Property Security Agreement Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 054836 and Frame 0765 and Reel 061314 and 0459 Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →